Telecharger Cours

INTERIM FINANCIAL REPORT AT 31 MARCH 2012 FINMECCANICA

Estimated tmax was 6.7 days (5th and 95th percentile: 4.4, 9.3) for casirivimab and 6.6 days (5th and 95th percentile: 4.4, 9.1) for imdevimab.



Download